CRSP CRISPR Therapeutics

• None no insider bought on the open market
• $781K sold by 1 insider outside a trading plan
• $11.1M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Simeon George Director
   Planned sale
   $720K 14,514 shares at $49.63 48% of stake
   Traded Oct 14 Filed Oct 16
   ↗
3. James R. Kasinger General Counsel and Secretary
   Planned sale
   $119K 1,990 shares at $60.04 2.1% of stake
   Traded Oct 6 Filed Oct 8
   ↗
4. James R. Kasinger General Counsel and Secretary
   Planned sale
   $626K 10,400 shares at $60.24 9.9% of stake
   Traded Sep 22 Filed Sep 24
   ↗
5. Ali Behbahani Director
   Sale
   $781K 13,679 shares at $57.09 45% of stake
   Traded Sep 17 Filed Sep 21
   ↗
6. Naimish Patel Chief Medical Officer
   Buy
   $50K 1,508 shares at $32.96 New stake
   Traded Apr 3, 2025 Filed Jan 27
   ↗
7. Raju Prasad CFO
   Planned sale
   $2.1M 34,972 shares at $60.19 84% of stake
   Traded Jan 22 Filed Jan 26
   ↗
8. Samarth Kulkarni CEO
   Planned sale
   $5.2M 90,000 shares at $57.40 40% of stake
   Traded Jan 20–22 Filed Jan 22
   ↗
9. Raju Prasad CFO
   Planned sale
   $1.8M 29,700 shares at $60.16 81% of stake
   Traded Jan 6 Filed Jan 8
   ↗
10. Raju Prasad CFO
    Planned sale
    $560K 10,000 shares at $55.95 60% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 option exercises, 16 sales to cover taxes, and 3 gifts.